Back

Residual risk following myocardial infarction despite intensive medical management

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Antiplatelet and anticoagulant drugs Cardiovascular Pharmacotherapy, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Robert Rosenson

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

5 More presentations in this session

Presentation thumbnail
Doctor T. Petroni (Montauban, FR)
Abstract
Presentation thumbnail
Associate Professor M. Klinceva (Skopje, MK)
Abstract Slides
Presentation thumbnail
Mrs A. Kosinova (Elvas, PT)
Abstract Slides
Presentation thumbnail
Doctor A. Almaghraby (Ras Al Khaimah, AE)
Abstract Slides
Presentation thumbnail
Doctor J. Michel (Austin, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Antiplatelet and anticoagulant drugs

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Residual cardiovascular risk and secondary cardiac events after acute myocardial infarction: prognostic insights and lipid challenges.
1 September 2025
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease
31 March 2025
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
17 November 2025
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources